Видео ютуба по тегу Fourier Trial

Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab i... | RTCL.TV
Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab i... | RTCL.TV
Safety and Efficacy of Very Low LDL-C (FOURIER-OLE Trial)
Safety and Efficacy of Very Low LDL-C (FOURIER-OLE Trial)
2-9-2023 - Updates on Lipid Management: New Tools in the New Era
2-9-2023 - Updates on Lipid Management: New Tools in the New Era
ESC TV at #ESCCongress 2022 - FOURIER-OLE
ESC TV at #ESCCongress 2022 - FOURIER-OLE
Professor Marc S. Sabatine - Have we reached the limits of lipid lowering and outcome
Professor Marc S. Sabatine - Have we reached the limits of lipid lowering and outcome
Non-Statin Therapies for LDL-C Lowering; How to Rationally Use Them
Non-Statin Therapies for LDL-C Lowering; How to Rationally Use Them
JACC FOURIER Study - Cognitive Function
JACC FOURIER Study - Cognitive Function
Clinical Outcomes With PCSK9 Inhibitors
Clinical Outcomes With PCSK9 Inhibitors
SYNTAX || Trial Fourier outcome Trial by Dr.Pankaj Jariwala
SYNTAX || Trial Fourier outcome Trial by Dr.Pankaj Jariwala
ESC 2017 Prof John Chapman discusses the implications of the new FOURIER analysis
ESC 2017 Prof John Chapman discusses the implications of the new FOURIER analysis
ACC FOURIER presentation video
ACC FOURIER presentation video
DOES VERY LOW LDL-C MEAN BETTER PROTECTION | FOURIER STUDY 2017 REVIEW NIK NIKAM MD
DOES VERY LOW LDL-C MEAN BETTER PROTECTION | FOURIER STUDY 2017 REVIEW NIK NIKAM MD
FOURIER: Use of PCSK9 inhibitor evolocumab - ACC.17
FOURIER: Use of PCSK9 inhibitor evolocumab - ACC.17
FOURIER
FOURIER
FOURIER Trial at ACC.17 - PCSK9 Inhibitors for Secondary Prevention
FOURIER Trial at ACC.17 - PCSK9 Inhibitors for Secondary Prevention
ESC TV at ACC.17 - FOURIER - A Second Look
ESC TV at ACC.17 - FOURIER - A Second Look
Results from FOURIER Trial Presented at #ACC17
Results from FOURIER Trial Presented at #ACC17
FOURIER Delivers Good News Globally
FOURIER Delivers Good News Globally